Product Information
AZITHROMYCIN 250 MG TABLET is a generic product labeled by TAGI Pharma Inc., priced at $0.3622 per EA under NDC 51224002218. Its NADAC has been published 279 times since Aug 21, 2019.
FDA first approved this application on Apr 17, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
TAGI Pharma Inc.NDC
51224002218
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
AZITHROMYCIN DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA208250FDA Approved
4/17/2019
TE Code
AB
On Market Since
7/1/2019
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN 250 MG TABLET has been published 279 times since Aug 21, 2019, and over the history we have for it it has declined 30.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3622 per EA |
|---|---|
| All-time high | $0.6650 (Apr 15, 2020) |
| All-time low | $0.2563 (Nov 20, 2024) |
| Median price | $0.3985 |
| Average price | $0.4451 |
| Largest weekly change | -35.6% (Nov 20, 2024) |
| Weeks tracked | 279 |
| Tracking since | Aug 21, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+6.0%
5Y
-32.1%
All
-30.8%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AZITHROMYCIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 250 MG TABLET, manufactured by TAGI Pharma Inc., is $0.3622 per EA (NDC 51224002218), effective Mar 5, 2025.
How has the price of AZITHROMYCIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN 250 MG TABLET has declined 30.8%. It has been tracked across 279 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 250 MG TABLET?
Since Aug 21, 2019, the NADAC for AZITHROMYCIN 250 MG TABLET has ranged from a low of $0.2563 (Nov 20, 2024) to a high of $0.6650 (Apr 15, 2020), with a median of $0.3985 per EA.
Are there cheaper alternatives to AZITHROMYCIN 250 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AZITHROMYCIN 250 MG TABLET, is $0.2676 per EA — about 26% below AZITHROMYCIN 250 MG TABLET.
Who manufactures AZITHROMYCIN 250 MG TABLET?
AZITHROMYCIN 250 MG TABLET (NDC 51224002218) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.